1 Day
Source:
بوابة الشروق
بوابة الشروق
Ready to play
Ready to play
A Japanese startup will conduct clinical trials in early 2028 to transplant genetically modified pig kidneys into humans, aiming to address the shortage of kidney donors in Japan. The experiments will take place at two hospitals affiliated with Hokkaido University and Shonan Kamakura University, with the hope that this technology will help treat patients with severe kidney failure after regulatory approval. These will be the first such trials in Japan, building on previous efforts in the United States and China.
Notice: This Is an AI-Generated Summary
Comments (0)